Skip to main content
. 2021 Mar 5;70(6):1404–1413. doi: 10.2337/db20-1167

Table 4.

Associations between GrimAge measurements at Y15–Y20 and incident T2D during Y15–Y30 by BMI status at Y15

Normal weight at Y15 (BMI <25 kg/m2, N = 315) Overweight at Y15 (BMI 25–30 kg/m2, N = 365) With obesity at Y15 (BMI ≥30 kg/m2, N = 287) Pinteraction
Model 1: diabetes vs. prediabetes and normal glucose
 Chronological age 1.21 (1.02–1.44)* 1.04 (0.93–1.17) 0.99 (0.92–1.07) 0.54
 GrimAge 1.01 (0.91–1.11) 1.03 (0.98–1.08) 1.01 (0.97–1.05) 0.13
 GrimAA 0.92 (0.81–1.05) 1.03 (0.96–1.09) 1.01 (0.96–1.07) 0.17
 Positive GrimAA 0.71 (0.21–2.44) 1.13 (0.60–2.14) 1.71 (1.12–2.60)* 0.69
 Positive 5yr GrimAA 0.64 (0.19–2.13) 0.70 (0.38–1.28) 1.86 (1.24–2.79)** <0.01
Model 2: diabetes vs. normal glucose (prediabetes excluded)
 Chronological age 1.26 (1.06–1.51)** 1.05 (0.93–1.19) 1.02 (0.93–1.11) 0.56
 GrimAge 1.03 (0.93–1.13) 1.03 (0.97–1.09) 1.01 (0.97–1.06) 0.06
 GrimAA 0.94 (0.83–1.07) 1.02 (0.96–1.09) 0.99 (0.93–1.06) 0.03
 Positive GrimAA 0.89 (0.25–3.14) 1.12 (0.56–2.25) 2.10 (1.29–3.41)* 0.54
 Positive 5yr GrimAA 0.65 (0.19–2.20) 0.70 (0.37–1.34) 1.90 (1.21–2.98)** <0.01
Model 3: hyperglycemia (diabetes or prediabetes) vs. normal glucose
 Chronological age 1.17 (1.10–1.24)*** 1.02 (0.96–1.09) 1.04 (0.97–1.11) 0.10
 GrimAge 1.06 (1.02–1.10)** 1.02 (0.99–1.05) 1.00 (0.97–1.04) <0.01
 GrimAA 1.02 (0.97–1.08) 1.03 (0.99–1.07) 0.97 (0.92–1.02) <0.01
 Positive GrimAA 1.60 (1.01–2.56)* 1.21 (0.85–1.73) 1.39 (0.96–2.00) 0.12
 Positive 5yr GrimAA 1.54 (1.05–2.25)* 1.65 (1.21–2.25)* 1.26 (0.88–1.79) 0.71

Data are OR (95% CI). Models are adjusted for race, sex, education, smoking status, physical activity, alcohol drinking, and field center.

For GrimAge and GrimAA, the ORs and 95% CIs were calculated based on 1-year increase of each measurement.

*

P < 0.05;

**

P < 0.01;

***

P < 0.001.